Accel has 58 tracked deals to Benchmark's 24. Stage focus, check size, and sector fit compared side by side. Verified investor data on StartupFundraising.com.
Accel is an active investor with 58 tracked deals. Benchmark is an active investor with 24 tracked deals. Accel shows 34 more tracked rounds than Benchmark in this dataset, which is the clearest signal of deployment pace between the two. Recent tracked names include Alyssum Therapeutics and Anysphere for Accel and Agentio and Anysphere for Benchmark.
Investors like Accel · Investors like Benchmark · Accel co-investors · Full investor directory